Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type

Frontiers in Genetics
Meng-Shin ShiaoNatini Jinawath

Abstract

Intrahepatic cholangiocarcinoma (ICC) is the cancer of the intrahepatic bile ducts, and together with hepatocellular carcinoma (HCC), constitute the majority of primary liver cancers. ICC is a rare disorder as its overall incidence is < 1/100,000 in the United States and Europe. However, it shows much higher incidence in particular geographical regions, such as northeastern Thailand, where liver fluke infection is the most common risk factor of ICC. Since the early stages of ICC are often asymptomatic, the patients are usually diagnosed at advanced stages with no effective treatments available, leading to the high mortality rate. In addition, unclear genetic mechanisms, heterogeneous nature, and various etiologies complicate the development of new efficient treatments. Recently, a number of studies have employed high-throughput approaches, including next-generation sequencing and mass spectrometry, in order to understand ICC in different biological aspects. In general, the majority of recurrent genetic alterations identified in ICC are enriched in known tumor suppressor genes and oncogenes, such as mutations in TP53, KRAS, BAP1, ARID1A, IDH1, IDH2, and novel FGFR2 fusion genes. Yet, there are no major driver genes with immediat...Continue Reading

References

Sep 9, 1992·International Journal of Cancer. Journal International Du Cancer·Y ShimizuT L Whiteside
Nov 1, 1990·Genes, Chromosomes & Cancer·P D StortoS M Gollin
Jan 1, 1988·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·Y KusakaJ Sato
Nov 14, 1997·In Vitro Cellular & Developmental Biology. Animal·M EnjojiM Tsuneyoshi
Dec 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N ChalasaniH Hoen
Jul 11, 2002·British Journal of Cancer·J-L KuJ-G Park
Sep 25, 2003·International Journal of Cancer. Journal International Du Cancer·Upama LiengswangwongMasanao Miwa
Nov 5, 2003·Journal of Hepato-biliary-pancreatic Surgery·Susumu Yamasaki
Mar 30, 2004·Proteomics·Chantragan SrisomsapJisnuson Svasti
Jul 13, 2004·Cancer Science·Satoshi YamamotoTakashi Tanaka
Jul 26, 2006·World Journal of Gastroenterology : WJG·Temduang LimpaiboonVajarabhongsa Bhudhisawasdi
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Natini JinawathYusuke Nakamura
Oct 13, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Luciana McLean, Tushar Patel
Apr 26, 2007·Annals of Surgery·Michelle L DeOliveiraRichard D Schulick
Jul 12, 2007·PLoS Medicine·Banchob SripaPaul J Brindley
Apr 15, 2008·Current Opinion in Gastroenterology·Banchob Sripa, Chawalit Pairojkul
Jan 14, 2010·Journal of Biomedicine & Biotechnology·Chantragan SrisomsapJisnuson Svasti
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Li LuRandy L Johnson
Jan 21, 2010·Cancer Science·Hai-Rim ShinSung-Tae Hong
Mar 6, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Huabang ZhouHeping Hu
Apr 9, 2010·The New England Journal of Medicine·Juan ValleUNKNOWN ABC-02 Trial Investigators
Apr 21, 2010·Proceedings of the National Academy of Sciences of the United States of America·Kwang-Pyo LeeDae-Sik Lim
Aug 3, 2010·Genes & Development·Samira BenhamoucheAndrea I McClatchey
Sep 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Atul SharmaSurendra Pal Chaudhary
Feb 24, 2011·Seminars in Liver Disease·Christine SempouxSwan N Thung
Mar 23, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Tsan-Hua YuYung-Ming Jeng
Mar 23, 2011·Cancer Causes & Control : CCC·Hong-Bo RenYan-Qing Li
Apr 12, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chyng-Wen FwuChien-Jen Chen
Apr 14, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gia L Tyson, Hashem B El-Serag
Apr 27, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tanios Bekaii-SaabMiguel A Villalona-Calero
Aug 23, 2011·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Wei JingXiangui Hu
Dec 17, 2011·Journal of Hepatology·Shahid A KhanMireille B Toledano
Dec 20, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jun Ho YiHo Yeong Lim
Mar 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L H JensenA Jakobsen
May 9, 2012·Nature Genetics·Choon Kiat OngBin Tean Teh
Jul 20, 2012·Journal of Gastrointestinal Oncology·Umashankar K Ballehaninna, Ronald S Chamberlain
Oct 2, 2012·The Journal of Clinical Investigation·Sayaka Sekiya, Atsushi Suzuki
Mar 19, 2013·Surgery·Omar HyderTimothy M Pawlik
Mar 26, 2013·Gastroenterology·Ágnes HolczbauerSnorri S Thorgeirsson

❮ Previous
Next ❯

Citations

Sep 12, 2020·The Innovation·Mei FengShaokun Shu
Jun 3, 2021·Journal of Clinical Medicine·Sudha KodaliRafik M Ghobrial

❮ Previous
Next ❯

Methods Mentioned

BETA
RNA-Seq
xenograft
xenografts
single cell sequencing

Clinical Trials Mentioned

NCT03230318
NCT02428855
NCT02073994
NCT02989857
NCT02496741
NCT02609958
NCT03043547
NCT03207347
NCT03027284
NCT03215511

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

Journal of Hepato-biliary-pancreatic Surgery
Iris TischoffAndrea Tannapfel
Journal of Hepato-biliary-pancreatic Sciences
Takeshi ItoYoshinori Murakami
Best Practice & Research. Clinical Gastroenterology
Sarinya KongpetchBin Tean Teh
Chinese Clinical Oncology
Louise C ConnellGhassan K Abou-Alfa
© 2022 Meta ULC. All rights reserved